SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001213900-22-027105
Filing Date
2022-05-16
Accepted
2022-05-16 16:10:57
Documents
51
Period of Report
2022-03-31

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT f10q0322_virpaxpharma.htm   iXBRL 10-Q 451489
2 CERTIFICATION f10q0322ex31-1_virpaxpharma.htm EX-31.1 10451
3 CERTIFICATION f10q0322ex31-2_virpaxpharma.htm EX-31.2 10467
4 CERTIFICATION f10q0322ex32-1_virpaxpharma.htm EX-32.1 5763
5 CERTIFICATION f10q0322ex32-2_virpaxpharma.htm EX-32.2 5816
  Complete submission text file 0001213900-22-027105.txt   2923001

Data Files

Seq Description Document Type Size
6 XBRL SCHEMA FILE vrpx-20220331.xsd EX-101.SCH 36267
7 XBRL CALCULATION FILE vrpx-20220331_cal.xml EX-101.CAL 19635
8 XBRL DEFINITION FILE vrpx-20220331_def.xml EX-101.DEF 156730
9 XBRL LABEL FILE vrpx-20220331_lab.xml EX-101.LAB 326589
10 XBRL PRESENTATION FILE vrpx-20220331_pre.xml EX-101.PRE 165765
45 EXTRACTED XBRL INSTANCE DOCUMENT f10q0322_virpaxpharma_htm.xml XML 251794
Mailing Address 1554 PAOLI PIKE #279 WEST CHESTER PA 19380
Business Address 1554 PAOLI PIKE #279 WEST CHESTER PA 19380 484-875-3195
Virpax Pharmaceuticals, Inc. (Filer) CIK: 0001708331 (see all company filings)

IRS No.: 821510982 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-40064 | Film No.: 22929049
SIC: 2834 Pharmaceutical Preparations